News
Cancer Study Headline, Translated: When RECIST and PFS Show Up
Study headlines often mention RECIST, response rate, and progression-free survival. Here is what those terms can and cannot tell patients.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
In brief
Many cancer study headlines use response-rate language such as RECIST, ORR, PFS, complete response, and partial response. Those terms are useful, but they are not the same as a personal prognosis.
This is part of Cancer Explained's recurring original-news format: Cancer study headline, translated. The goal is to translate a headline into patient questions, not to turn a news item into personal medical advice.
What changed
This explainer adds a study-literacy lens to common trial terms so patients can ask better questions after reading a headline.
Why it matters
A treatment can improve one endpoint without answering every patient question about symptoms, survival, quality of life, or side effects.
What this does not mean
- It does not mean the news applies to every person with cancer.
- It does not replace a treatment plan from a care team.
- It does not prove that one option is best for every patient.
- It does not mean a person should start, stop, or change treatment without medical advice.
Questions patients can ask
- What endpoint did the study measure?
- Was the study randomized?
- How many people were included?
- Did people live longer, feel better, or just have slower scan growth?
- Does my situation match the trial population?
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels unsafe or unclear? Report it here - we log and act on material corrections.